Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.5463
H.R.5463: Drug Pricing Transparency and Accountability Act
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced Sept. 30, 2021
- Latest Major Action Oct. 1, 2021
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Version
- Introduced in House - Sept. 30, 2021
Bill Summary
Drug Pricing Transparency and Accountability Act This bill establishes a two-year moratorium on allowing new, non-rural hospitals and associated child sites to participate in the 340B drug pricing program; during the moratorium, the Department of Health and Human Services must issue regulations with specified program eligibility standards. The bill also requires additional reporting relating to program participation, eligibility, and costs.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| Oct. 1, 2021 |
Referred to the Subcommittee on Health.
|
| Sept. 30, 2021 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
| Sept. 30, 2021 |
Introduced in the House by Matt Rosendale (R-Mont.) |